Page last updated: 2024-10-31

metyrapone and Infant, Premature, Diseases

metyrapone has been researched along with Infant, Premature, Diseases in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alkalay, AL1
Klein, AH1
Nagel, RA1
Pomerance, JJ1

Other Studies

1 other study available for metyrapone and Infant, Premature, Diseases

ArticleYear
Evaluation of hypothalamic-pituitary-adrenal axis in premature infants treated with dexamethasone.
    American journal of perinatology, 1996, Volume: 13, Issue:8

    Topics: Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Dexamethasone; Glucocorticoids; Humans

1996